| scholarly article | Q13442814 |
| P2093 | author name string | Ye Tao | |
| Wen Chen | |||
| Miao He | |||
| Yingxin Qu | |||
| Zhao Ma | |||
| Guanghua Peng | |||
| Qinghua Yang | |||
| Dengke Teng | |||
| P2860 | cites work | Evaluation of the Night Vision Spectacles on patients with impaired night vision. | Q52224410 |
| DNA Damage Response in Proliferating Müller Glia in the Mammalian Retina. | Q52880786 | ||
| Retinal Degeneration Associated with Taurine Deficiency in the Cat | Q55034845 | ||
| Activation of Bax in Three Models of Retinitis Pigmentosa | Q59301323 | ||
| Neurochemical development of the degenerating rat retina | Q59464942 | ||
| Immunocytochemical localization of taurine in the mammalian retina | Q69598368 | ||
| Reductions in taurine secondary to photoreceptor loss in Irish setters with rod-cone dysplasia | Q70110890 | ||
| Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia | Q80827012 | ||
| Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study | Q86033373 | ||
| Taurine Depletion Causes ipRGC Loss and Increases Light-Induced Photoreceptor Degeneration | Q88293568 | ||
| Taurine is a crucial factor to preserve retinal ganglion cell survival | Q39012863 | ||
| Taurine Promotes Retinal Ganglion Cell Survival Through GABAB Receptor Activation | Q39040350 | ||
| Quantitative and Topographical Analysis of the Losses of Cone Photoreceptors and Retinal Ganglion Cells Under Taurine Depletion | Q39040362 | ||
| What can pharmacological models of retinal degeneration tell us? | Q39254299 | ||
| Uptake of taurine by platelets in retinitis pigmentosa | Q39534713 | ||
| Ceramide is the key mediator of oxidative stress-induced apoptosis in retinal photoreceptor cells. | Q40241323 | ||
| Distribution of cone photoreceptors in the mammalian retina | Q41336930 | ||
| mTORC1 sustains vision in retinitis pigmentosa | Q43195494 | ||
| Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study | Q44152193 | ||
| Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt/caspase-9 pathway | Q44799560 | ||
| Light deprivation slows but does not prevent the loss of photoreceptors in taurine transporter knockout mice | Q44900895 | ||
| Mechanism of neuroprotective function of taurine | Q46111213 | ||
| A Novel Role of SIRT1/ FGF-21 in Taurine Protection Against Cafeteria Diet-Induced Steatohepatitis in Rats | Q46228119 | ||
| Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications. | Q46687029 | ||
| Retinal degeneration induced by taurine deficiency in light-deprived cats | Q48325502 | ||
| Taurine increases mitochondrial buffering of calcium: role in neuroprotection | Q48428352 | ||
| Cone degeneration is triggered by the absence of USH1 proteins but prevented by antioxidant treatments | Q49196891 | ||
| Anthocyanin can arrest the cone photoreceptor degeneration and act as a novel treatment for retinitis pigmentosa | Q28070225 | ||
| TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD | Q28219450 | ||
| Taurine provides neuroprotection against retinal ganglion cell degeneration | Q28484543 | ||
| Retinitis pigmentosa | Q29616538 | ||
| Amino acids in retinitis pigmentosa | Q33641388 | ||
| Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats. | Q33828809 | ||
| Role of osmoregulation in the actions of taurine | Q34119781 | ||
| Taurine deficiency damages retinal neurones: cone photoreceptors and retinal ganglion cells. | Q34265957 | ||
| Review: taurine: a "very essential" amino acid. | Q34312980 | ||
| Reciprocal regulation between taurine and glutamate response via Ca2+-dependent pathways in retinal third-order neurons | Q34364351 | ||
| A system to measure the Optokinetic and Optomotor response in mice | Q36296467 | ||
| NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study | Q36447300 | ||
| Susceptibility to N-methyl-N-nitrosourea-induced retinal degeneration in different rat strains | Q36616004 | ||
| Use of Hydrogen as a Novel Therapeutic Strategy Against Photoreceptor Degeneration in Retinitis Pigmentosa Patients. | Q36672903 | ||
| Taurine uptake across the human intestinal brush-border membrane is via two transporters: H+-coupled PAT1 (SLC36A1) and Na+- and Cl(-)-dependent TauT (SLC6A6) | Q37160620 | ||
| Pharmacology of taurine. | Q37208590 | ||
| Taurine Treatment Modulates Circadian Rhythms in Mice Fed A High Fat Diet | Q37421953 | ||
| Mechanisms of apoptosis in retinitis pigmentosa. | Q37438228 | ||
| Animal models for retinitis pigmentosa induced by MNU; disease progression, mechanisms and therapeutic trials | Q37760867 | ||
| Taurine: the comeback of a neutraceutical in the prevention of retinal degenerations | Q38203649 | ||
| Physiological role of taurine--from organism to organelle | Q38241705 | ||
| Pharmacological approaches to retinitis pigmentosa: A laboratory perspective | Q38538231 | ||
| Taurine in the central nervous system and the mammalian actions of taurine | Q38663407 | ||
| A review of the mechanisms of cone degeneration in retinitis pigmentosa | Q38879021 | ||
| A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: a better understanding of the pathophysiology using the newest genetic strategies | Q38937867 | ||
| Mechanisms of Photoreceptor Patterning in Vertebrates and Invertebrates | Q38951133 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 2689-2702 | |
| P577 | publication date | 2019-08-07 | |
| P1433 | published in | Drug Design, Development and Therapy | Q2566724 |
| P1476 | title | Systemic taurine treatment provides neuroprotection against retinal photoreceptor degeneration and visual function impairments | |
| P478 | volume | 13 |
Search more.